Biomarkers for the early detection of relapses in metastatic colorectal cancers.

CONCLUSIONS: The evaluated biomarkers could be useful prognostic factors for survival. Baseline CEA also has predictive value, suggesting that patients with low levels do not benefit from bevacizumab. A non-statistically significant correlation was observed between the number of CTCs and outcome. PMID: 28730771 [PubMed - in process] (Source: Journal of B.U.ON.)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uMGmhW
via IFTTT